Navamedic ASA (FRA:N1A)

Market Cap	47.92M +26.0%
Revenue (ttm)	46.03M +2.6%
Net Income	-3.23M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	115.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	80
Open	1.840
Previous Close	1.840
Day's Range	1.840 - 1.845
52-Week Range	1.490 - 2.180
Beta	n/a
RSI	59.51
Earnings Date	Feb 12, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 42
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N1A

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial numbers in NOK